Anthony S. Murabito
Corporate Officer/Principal presso New Jersey Society of Health-System Pharmacists
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| James Ford | M | - | 29 anni | |
| David Redfern | M | 57 | 30 anni | |
| Timothy Woodthorpe | M | - | 24 anni | |
| Graham Rivers | M | - | 26 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Julian Heslop | M | 70 | 13 anni | |
| Kurt C. Gunter | M | 69 |
Transkaryotic Therapies, Inc.
 Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 5 anni |
| Robert Carr | M | - | 26 anni | |
| William Louv | M | - | 21 anni | |
| Michèle Barzach | M | - | 7 anni | |
| John David Coombe | M | 79 | 5 anni | |
| Peter Traber | M | 69 | 3 anni | |
| Richard Sykes | M | 79 | 7 anni | |
| Alex Howarth | M | 55 | 10 anni | |
| Christopher Viehbacher | M | 64 | 20 anni | |
| Murray Stewart | M | 63 | 17 anni | |
| Robert P. Roche | M | 68 | - | |
| John Lepore | M | - | 15 anni | |
| Jay C. Strum | M | - | 14 anni | |
| Thierry Loriot | M | - | - | |
| Roger Connor | M | - | 24 anni | |
| Charlie Sanders | M | 91 | 5 anni | |
| Catherine Sohn | M | 71 | 28 anni | |
| James Wu | M | - | 10 anni | |
| Robin M. Young | M | 57 | 7 anni | |
| David Wheadon | M | 66 | 5 anni | |
| Lawson Macartney | M | 66 | 12 anni | |
| Anne Brindley | M | 59 | 3 anni | |
| David M. Pernock | M | 69 | 16 anni | |
| Peter John Murray | M | - | - | |
| Carol Ashe | F | 66 | 13 anni | |
| Duncan Learmouth | M | - | - | |
| Neil Pegg | M | - | - | |
| Steven Gelone | M | 56 | 2 anni | |
| Gregg Brandyberry | M | - | 16 anni | |
| Dean Hakanson | M | 72 | 7 anni | |
| Michael Allen Luther | M | 67 | 15 anni | |
| Myra Rosario Herrle | M | - | 9 anni | |
| Tina Russell | F | - | 1 anni | |
| Song Gao | M | 52 | 22 anni | |
| Monica Viziano | M | 57 | 6 anni | |
| Hu Li | M | 59 | 19 anni | |
| Ian Pitfield | M | 58 | 23 anni | |
| Lisa Trivison Beck | F | 62 | 24 anni | |
| Melissa Beelen | F | - | 12 anni | |
| David Rowe | M | 57 | 20 anni | |
| Edgar Cale | M | 60 | 21 anni | |
| Lisa Bright | F | 56 | 17 anni | |
| Kimberly Park | F | 60 | 12 anni | |
| Daniel G. Marquess | M | 55 | 4 anni | |
| Steve Damment | M | - | 17 anni | |
| Deborah Waterhouse | F | 57 | - | |
| Vivid Sehgal | M | 56 | 6 anni | |
| Brian Blakey | M | 61 | 6 anni | |
| Nick Hirons | M | - | - | |
| Adi Mohanty | M | 57 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 anni |
| Scott Fields | M | 69 | 5 anni | |
| Robert G. Pietrusko | M | 76 | 1 anni | |
| David Laskow-Pooley | M | 70 | 8 anni | |
| Randall K. Johnson | M | 77 | 20 anni | |
| Tamar Howson | F | 75 | 9 anni | |
| Richard A. Franco | M | 82 | 12 anni | |
| Howard H. Pien | M | 66 | 12 anni | |
| Paul W. Hawran | M | 71 | 9 anni | |
| George Poste | M | 79 | 7 anni | |
| Konstantinos Andrikopoulos | M | 58 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 anni |
| Joseph M. Spagnardi | M | 60 | 11 anni | |
| Faheem Hasnain | M | 65 | 14 anni | |
| Leslie Hudson | M | 76 | 6 anni | |
| Paul Magrez | M | - | 4 anni | |
| Ursula B. Bartels | F | 66 | 11 anni | |
| Maxine Gowen | M | 66 | 10 anni | |
| Thomas Sciascia | M | 70 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 1 anni |
| Robert Ruffolo | M | 74 | 16 anni | |
| Tim Tyson | M | 71 | 6 anni | |
| Dean Mitchell | M | 68 | 15 anni | |
| Roger L. Hawley | M | 71 | 14 anni | |
| Joseph Schachle | M | 59 | 3 anni | |
| Renato Fuchs | M | 80 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 4 anni |
| William J. Fallon | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 anni |
| Lieven Nuyttens | M | 57 | 6 anni | |
| David Lawrence | M | 61 | 13 anni | |
| Franco di Muzio | M | - | 8 anni | |
| Paul Carter | M | 63 | 10 anni | |
| Margaret Dalesandro | M | 77 | 2 anni | |
| Marc Rubin | M | 69 | 13 anni | |
| Christopher J. Morl | M | 65 | 3 anni | |
| Dimitri Dimitriou | M | - | 5 anni | |
| Douglas B. Snyder | M | 60 | 6 anni | |
| Shirish Hirani | M | - |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 3 anni |
| Daniel Phelan | M | 74 | 31 anni | |
| Argeris Karabelas | M | 71 | 6 anni | |
| Adrian Rawcliffe | M | 52 | 17 anni | |
| Lisa Porter | M | 60 | 5 anni | |
| Michael V. Milburn | M | - | 10 anni | |
| Elaine Jones | M | 69 | - | |
| Christoph Adams | M | 67 |
Transkaryotic Therapies, Inc.
Transkaryotic Therapies, Inc. Miscellaneous Commercial ServicesCommercial Services Transkaryotic Therapies, Inc. (TKT) was a biopharmaceutical company with a major focus on developing products for the treatment of rare diseases. The company is used to markets one product, Replagal™, for the treatment of Fabry disease in the European Union and other countries, and was developing products for Hunter syndrome and Gaucher disease. The company was located in Cambridge, MA. | 7 anni |
| Gary Patou | M | 65 | 5 anni | |
| Leon Palandjian | M | 54 | 3 anni | |
| Geoffrey Nichol | M | 69 | 7 anni | |
| Wissam Al-Adani | M | 50 | 6 anni |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Regno Unito | 92 | 92.00% |
| Stati Uniti | 8 | 8.00% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Anthony S. Murabito
- Contatti personali
